Status:
WITHDRAWN
Comprehensive Geriatric Assessment in Elderly Non-Small Cell Lung Cancer Patients
Lead Sponsor:
University of Hull
Collaborating Sponsors:
Hull University Teaching Hospitals NHS Trust
Conditions:
Lung Cancer
Non-small Cell Lung Cancer
Eligibility:
All Genders
70+ years
Brief Summary
Lung cancer is responsible for one of the highest incidences of cancer-related mortality globally, and non-small cell lung cancer (NSCLC) accounts for the biggest subtype of lung cancer. In recent yea...
Eligibility Criteria
Inclusion
- Patients ≥70 years old with advanced NSCLC due to start first or second line ICI therapy.
- Patients able to give informed consent.
Exclusion
- Patients already on treatment with ICIs.
- Patients with CNS or leptomeningeal spread / disease progression.
- ECOG performance status III/IV.
- Patients with severe autoimmune diseases.
- Patients who are recruited and then stop treatment after receiving ≤3 cycles of ICI therapy, secondary to disease progression.
Key Trial Info
Start Date :
February 9 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05230888
Start Date
February 9 2022
End Date
November 1 2022
Last Update
September 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Castle Hill Hospital
Cottingham, Hull, United Kingdom, HU16 5JQ